Related Experiment Videos
Cyclocryotherapy as an alternative treatment for primary glaucoma.
1Dept. of Ophthalmology, A.Z.-V.U.B., Brussels, Belgium.
Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1992
Summary
Cyclocryotherapy offers a successful alternative for primary glaucoma treatment, significantly reducing intraocular pressure. While many patients require additional medication, this method shows good efficacy with few severe complications.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Interventions
Background:
- Primary glaucoma, encompassing both narrow and open-angle types, presents a significant challenge in intraocular pressure (IOP) management.
- Traditional treatments like trabeculectomy carry risks of severe complications.
- Alternative therapeutic strategies are needed to improve patient outcomes and safety profiles.
Purpose of the Study:
- To evaluate the efficacy and safety of cyclocryotherapy as a primary treatment for patients with primary glaucoma.
- To assess both short-term and long-term outcomes, including IOP control and complication rates.
Main Methods:
- A prospective study involving 56 patients with primary glaucoma (narrow and open-angle) treated with cyclocryotherapy.
- Prospective IOP measurements and follow-up assessments.
- Retrospective evaluation of long-term efficacy in 21 patients with a mean follow-up of 51 months.
Main Results:
- Short-term success (Peak IOP ≤ 20 mm Hg) was achieved in 87.7% of cases, with a mean IOP reduction from 29.7 mm Hg to 17.25 mm Hg.
- Approximately 60% of eyes required supplemental local treatment.
- Long-term (mean 51 months) efficacy showed 58.3% of eyes remained controlled, though 26.6% experienced visual field deterioration despite normotensive IOP.
Conclusions:
- Cyclocryotherapy demonstrates significant short-term efficacy in lowering intraocular pressure for primary glaucoma.
- The procedure is associated with rare and mild postoperative complications.
- Given its favorable safety profile compared to trabeculectomy, cyclocryotherapy is proposed as a potential first-line treatment for primary glaucoma, acknowledging the need for ongoing monitoring and potential adjunctive therapies.